Merck & Co.
AWARDS
NEWS
The new research hub will be called the London Discovery Research Centre and is expected to open by 2025.
Merck entered into an exclusive licensing deal with Hanmi Pharmaceutical for the development, manufacture and commercialization of efinopegdutide for nonalcoholic steatohepatitis (NASH).
Merck is joining the ranks of pharmaceutical companies that have a COVID-19 vaccine candidate in clinical development. Merck will move its candidate into clinical trials in the third quarter of this year, the company announced this morning.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 31, 2020.
In an ongoing online hearing before the House Committee on Energy and Commerce’s Oversight and Investigation subcommittee, executives from across the pharmaceutical industry outlined the steps their companies are taking to combat COVID-19 and restore the world to a sense of normalcy.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 22, 2020.
JOBS
IN THE PRESS